Flexion Therapeutics Competitors and Similar CompaniesClear all
Flexion Therapeutics's competitors and similar companies include Ipsen, Fujifilm Diosynth Biotechnologies, Chiesi Group and YiChang HEC ChangJiang Pharmaceutical.
 Flexion Therapeutics Flexion Therapeutics is a biotechnology company that develops long-lasting intra-articular injection therapies to treat osteoarthritis. |  Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry. |  Chiesi Group Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions. |  YiChang HEC ChangJiang Pharmaceutical YiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products. | ||
Founding Date | Founding Date 2007 | Founding Date 1929 | Founding Date 2011 | Founding Date 1935 | Founding Date 2001 |
Type | Type Subsidiary | Type Public | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Burlington, US HQ | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations Morrisville, US HQ Hillerød, DK Stockton On Tees, GB College Station, US | Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more | Locations HQ |
Employees | Employees 284% increase | Employees 5,358 | Employees 5,3942% increase | Employees 5,8541% increase | Employees 4,595 |
Financial | |||||
Revenue (est.) | Revenue (est.) $85.6m (FY, 2020) | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €2.4b (Y, 2021) | Revenue (est.) ¥3.7b (FY, 2024) |
Cost of goods | Cost of goods $19.2m (FY, 2020) | Cost of goods €659.1m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥533.6m (FY, 2024) |
Gross profit | Gross profit $66.3m (FY, 2020) | Gross profit €3.3b (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit ¥3.2b (FY, 2024) |
Net income | Net income ($113.7m) (FY, 2020) | Net income €445.1m (FY, 2025) | Net income N/A | Net income N/A | Net income ¥482.7m (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised $ 62m | Total funding raised N/A | Total funding raised $ 850m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Fujifilm Diosynth Biotechnologies
HQ
Morrisville, US
Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry.
View companyChiesi Group
HQ
Parma, IT
Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.
View companyYiChang HEC ChangJiang Pharmaceutical
HQ
Employees
4,595
YiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products.
View company